Date of Report (Date of earliest event reported):February 17, 2026
_____________________________
Medtronic plc
(Exact name of Registrant as Specified in its Charter)
_____________________________
Ireland
1-36820
98-1183488
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
Building Two
Parkmore Business Park West
Galway, Ireland
(Address of principal executive offices) (Zip Code)
+3531438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Ordinary shares, par value $0.0001 per share
MDT
New York Stock Exchange
1.125% Senior Notes due 2027
MDT/27
New York Stock Exchange
0.375% Senior Notes due 2028
MDT/28
New York Stock Exchange
3.000% Senior Notes due 2028
MDT/28A
New York Stock Exchange
3.650% Senior Notes due 2029
MDT/29
New York Stock Exchange
2.950% Senior Notes due 2030
MDT/30
New York Stock Exchange
1.625% Senior Notes due 2031
MDT/31
New York Stock Exchange
1.000% Senior Notes due 2031
MDT/31A
New York Stock Exchange
3.125% Senior Notes due 2031
MDT/31B
New York Stock Exchange
0.750% Senior Notes due 2032
MDT/32
New York Stock Exchange
3.375% Senior Notes due 2034
MDT/34
New York Stock Exchange
3.875% Senior Notes due 2036
MDT/36
New York Stock Exchange
2.250% Senior Notes due 2039
MDT/39A
New York Stock Exchange
1.500% Senior Notes due 2039
MDT/39B
New York Stock Exchange
1.375% Senior Notes due 2040
MDT/40A
New York Stock Exchange
4.150% Senior Notes due 2043
MDT/43A
New York Stock Exchange
4.200% Senior Notes due 2045
MDT/45
New York Stock Exchange
1.750% Senior Notes due 2049
MDT/49
New York Stock Exchange
1.625% Senior Notes due 2050
MDT/50
New York Stock Exchange
4.150% Senior Notes due 2053
MDT/53
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.
Results of Operations and Financial Condition
On February 17, 2026, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its third quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Cover Page Interactive Data File (embedded with the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Medtronic plc
By
/s/ Thierry Piéton
Date: February 17, 2026
Thierry Piéton
Executive Vice President and Chief Financial Officer (Principal Financial Officer)